Nature communications · 2026
CenSegNet: a generalist high-throughput deep learning framework for centrosome phenotyping at spatial and single-cell resolution in heterogeneous tissues.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Cheng Jiaoqi, Fan Keqiang, Bailey Miles, Du Xin, Jena Rajesh, Savva Constantinos, Reed Ewan, Gou Mengyang, Zuo Peixin, Cutress Ramsey, Beers Stephen, Cai Xiaohao, Elias Salah
Аннотация
Centrosome abnormalities (CA) are a hallmark of epithelial cancers, yet their spatial complexity and phenotypic heterogeneity remain poorly understood due to limitations in conventional image analysis. Here we present CenSegNet (Centrosome Segmentation Network), a modular deep learning framework for high-throughput segmentation of centrosomes and epithelial architecture, enabling accurate and generalisable centrosome phenotyping at spatial and single-cell resolution across imaging modalities and tissue contexts. Applied to tissue microarrays comprising 911 breast cancer cores from 127 patients, CenSegNet enables large-scale, spatially resolved quantification of numerical and structural CA. We show that these CA subtypes are mechanistically uncoupled, exhibiting distinct spatial distributions, age-dependent dynamics, and associations with tumour grade, hormone receptor status, genomic alterations and nodal involvement. Structural CA are associated with overall survival, whereas discordant CA profiles at tumour margins correlate with local tumour aggressiveness and stromal remodelling. These findings establish CenSegNet as a scalable platform for spatially resolved centrosome phenotyping, enabling systematic investigation of centrosome biology and its dysregulation in cancer and other epithelial diseases.